NEW WEIGHT LOSS
MEDICATIONS
Doctor-supervised weight-loss
medications for optimal results
*By submitting this form you agree to be contacted via text/phone/email.
Reply “Stop” to opt out.
Wegovy (generic name: Semaglutide), a drug treatment recently approved by the Food and Drug Administration (FDA) for chronic weight management, is administered via subcutaneous injection. It mimics the hormone known as glucagon-like peptide-1 (GLP-1), a substance that affects the areas of the brain that help regulate food intake and appetite.
Wegovy is intended for patients with excess weight and obesity who have a BMI of 30 or higher or a BMI of 27 or higher with an additional obesity-related health problem. The medication is intended to supplement a habit of increased physical activity as well as a reduced calorie diet; Wegovy alone isn’t likely to have the intended outcome of weight loss.
In the clinical trials that led to FDA approval, People who received Wegovy lost an average of 14.9% of their initial body weight during the 68-week trial. Those who received a placebo lost only 2.4% of their body weight.
While individual results will vary, the average weight loss in the Wegovy clinical trials was approximately 15% of body weight.
Nausea is the most common side effect of Wegovy, followed by diarrhea or constipation. The very low starting dose is intentional, so that your body can adjust to the medication. Most symptoms improve with time. In the clinical trials of Wegovy, approximately 4.5% of patients stopped their medication due to side effects.
Your medical provider will review your medical history during your initial consultation, to determine if Wegovy is the right medication for you. In some circumstances, it may not be recommended. For example, if you are using a different GLP-1 medication, you cannot combine it with Wegovy. Also, patients with a personal or family history of medullary thyroid cancer should not use Wegovy. It is also contraindicated if you have a rare genetic syndrome known as multiple endocrine neoplasia (MEN2).
Wegovy is contraindicated in patients with a personal or family history of medullary thyroid cancer, which is a rare type of thyroid cancer. However, it is safe to use if you have a history of hypothyroidism, hyperthyroidism, or currently take thyroid medication.
The medication itself will need to be obtained with your prescription coverage.
In the event that your insurance doesn’t cover this medication, we will provide you with in-house alternatives at a fraction of the cost.
Mounjaro (generic name: tirzepatide) is the newest injectable medication for the treatment of type II diabetes and obesity. Mounjaro was recently approved for diabetes and is expected to be FDA approved for the treatment of obesity.
Mounjaro is intended for adults with a BMI greater than 30, or greater than 27 with an obesity-related medical condition (i.e. diabetes, high blood pressure, high cholesterol, sleep apnea).
Patients must understand that Mounjaro is intended for long-term use by weekly subcutaneous injections.
*While Mounjaro (tirzepatide) is currently FDA approved for the treatment of type 2 diabetes in adults, it has not yet received FDA approval for the specific treatment of obesity.
The recently published SURMOUNT trial established the efficacy of Mounjaro. In this phase 3, controlled study, patients were randomized to receive either tirzepatide (at 5, 10 or 15 mg) or a placebo. After 72 weeks of treatment, the following results were observed:
The most common side effects of tirzepatide are gastrointestinal, similar to the side effects of semaglutide. They include nausea, diarrhea, and constipation. Mostly, these side effects are shown to be mild and transient, and occur during the dose-escalation period. In the SURMOUNT study, up to 7 percent of patients needed to stop their treatment due to side effects. Other rare side effects include pancreatitis and gallbladder disease, although the study showed that these were no more frequent with Mounjaro than with the placebo.
Mounjaro is contraindicated in patients with a personal or family history of medullary thyroid cancer, which is a rare type of thyroid cancer. However, it is safe to use if you have a history of hypothyroidism, hyperthyroidism, or currently take thyroid medication.
The medication itself will need to be obtained with your prescription coverage. In the event that your insurance doesn’t cover this medication, we will provide you with in-house alternatives at a fraction of the cost.
Are you searching for a way to achieve your weight loss goals while managing other aspects of your well-being? Wellbutrin, a medication primarily used to treat depression and anxiety, has gained attention for its potential to support weight loss. As you explore your options, consider how Wellbutrin could play a role in your journey towards a healthier you.
Wellbutrin is known to have an impact on weight, but the effects can vary from person to person. While some individuals may experience weight loss with Wellbutrin, others might find that their weight remains stable or undergoes changes. Factors such as dosage, individual metabolism, and overall lifestyle can contribute to the observed outcomes.
Many individuals turn to Wellbutrin for its potential to assist in weight loss. Reports of wellbutrin 150 mg weight loss, wellbutrin 300 xl weight loss, and even wellbutrin 450 mg weight loss have sparked interest in its effectiveness. The relationship between wellbutrin and weight loss is complex and multifaceted, often influenced by biological, psychological, and behavioral factors.
Struggling with anxiety while pursuing weight loss can be a challenging experience. Fortunately, Wellbutrin offers a dual benefit of potentially alleviating anxiety symptoms while aiding in weight loss efforts. The combination of wellbutrin for anxiety and weight loss has shown promise in providing individuals with a holistic approach to well-being.
If you’re considering wellbutrin for weight loss, it’s essential to consult with a medical professional before making any decisions. An expert can evaluate your unique circumstances, discuss potential benefits and risks, and provide guidance on the most suitable approach for your goals.
Real-life experiences can shed light on the potential of wellbutrin for weight loss. Wellbutrin weight loss stories offer insights into individuals who have incorporated the medication into their weight loss journeys. These stories provide hope, inspiration, and a sense of camaraderie for those navigating their own path to better health.
While wellbutrin side effects weight loss may be a desirable outcome, it’s crucial to consider the broader spectrum of potential effects. Consulting a healthcare professional can help you understand the balance between potential benefits and side effects to make an informed decision.
Wellbutrin weight loss medication is not a one-size-fits-all solution. By collaborating with medical professionals, you can develop a comprehensive approach that includes wellbutrin, dietary adjustments, exercise, and other strategies tailored to your needs.
The extended-release formulation of Wellbutrin, known as Wellbutrin XL, has shown promise in supporting weight loss efforts. Wellbutrin xl 150 mg weight loss and wellbutrin xl weight loss stories illustrate the potential effectiveness of this medication in various individuals.
*By submitting this form you agree to be contacted via text/phone/email.
Reply “Stop” to opt out.